Entry of bilirubin into the brain due to opening of the blood-brain barrier.
D000818:Animals; D001089:Arabinose / Q000008:administration & dosage; D001663:Bilirubin / Q000008:administration & dosage / Q000378:metabolism*; D001812:Blood-Brain Barrier / Q000187:drug effects*; D001921:Brain / Q000378:metabolism*; D004195:Disease Models, Animal; D006801:Humans; D006982:Hypertonic Solutions; D007231:Infant, Newborn; D007647:Kernicterus / Q000378:metabolism*; D011485:Protein Binding; D051381:Rats; D012709:Serum Albumin / Q000378:metabolism
D006982:Hypertonic Solutions; D012709:Serum Albumin; D001089:Arabinose; D001663:Bilirubin